Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ipratropium Bromide (Atrovent®) Used to Treat Exercise Induced Laryngeal Obstruction (EILO). An Open Label Pilot Study

NCT02755714 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT02755714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02755714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ipratropium Bromide (Atrovent®) Used to Treat Exercise Induced Laryngeal Obstruction (EILO). An Open Label Pilot Study
Lead sponsor
Haukeland University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
June 22, 2016
Completion date
October 31, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exercise induced laryngeal obstruction (eilo)